Premium
The Essential Medicines List for a Global Patient Population
Author(s) -
Robertson J,
Hill S R
Publication year - 2007
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/sj.clpt.6100392
Subject(s) - procurement , essential medicines , quality (philosophy) , medicine , selection (genetic algorithm) , risk analysis (engineering) , population , business , alternative medicine , drug development , computer science , environmental health , drug , public health , marketing , pharmacology , nursing , philosophy , epistemology , pathology , artificial intelligence
Thirty years after its inception, the role, audience, and contents of the global Essential Medicines List (EML) are reviewed. Challenges for decision makers in applying the principles of medicine selection based on efficacy, safety, burden of disease, and cost effectiveness are discussed and illustrated with recent decisions of the Expert Committee. Areas of controversy for decision makers are highlighted, and the advocacy role of the EML for both drug procurement and development of quality‐assured products is described. Clinical Pharmacology & Therapeutics (2007) 82 , 498–500. doi: 10.1038/sj.clpt.6100392